Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Current Leases (2022 - 2025)

Core Laboratories (CLB) has 4 years of Current Leases data on record, last reported at $11.5 million in Q3 2025.

  • For Q3 2025, Current Leases changed 0.34% year-over-year to $11.5 million; the TTM value through Sep 2025 reached $11.5 million, changed 0.34%, while the annual FY2024 figure was $10.7 million, 5.06% up from the prior year.
  • Current Leases reached $11.5 million in Q3 2025 per CLB's latest filing, roughly flat from $11.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $11.7 million in Q4 2022 and bottomed at $9.8 million in Q3 2023.
  • Average Current Leases over 4 years is $11.0 million, with a median of $11.0 million recorded in 2024.
  • Peak YoY movement for Current Leases: decreased 13.03% in 2023, then increased 16.76% in 2024.
  • A 4-year view of Current Leases shows it stood at $11.7 million in 2022, then decreased by 13.03% to $10.2 million in 2023, then rose by 5.06% to $10.7 million in 2024, then increased by 7.33% to $11.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $11.5 million in Q3 2025, $11.5 million in Q2 2025, and $11.7 million in Q1 2025.